Sperm mosaicism: implications for genomic diversity and disease

Area of Science:

• Genetics
• Reproductive Biology
• Developmental Biology

Background:

• Sperm mosaicism involves genetic mutations in sperm cells, impacting offspring and future generations.
• Emergent technologies reveal sperm mosaicism as a common source of de novo mutations (DNMs).
• These DNMs are linked to severe pediatric diseases and contribute to human genetic diversity.

Purpose of the Study:

• To categorize sperm mosaicism into distinct types based on origin and inheritance patterns.
• To elucidate the role of sperm mosaicism in de novo mutations and genetic diversity.
• To explore the potential for new sequencing technologies to assess and mitigate associated disease risks.

Main Methods:

• Review and synthesis of recent studies on sperm mosaicism and de novo mutations.
• Classification of sperm mosaicism into three types (I, II, and III) based on their developmental origins.
• Discussion of the implications of each type for recurrence risk and genetic diversity.

Main Results:

• Sperm mosaicism is classified into Type I (meiotic, non-age-dependent), Type II (spermatogonial, age-dependent), and Type III (embryonic, stable).
• Types I and II have low recurrence risk, while Type III may pose identifiable risks to offspring.
• Sperm mosaicism is a major contributor to human genetic diversity.

Conclusions:

• Sperm mosaicism is a key factor in de novo mutations, impacting pediatric disease and human genetic diversity.
• Understanding the distinct types of sperm mosaicism is crucial for assessing recurrence risks.
• Advanced sequencing technologies offer potential for evaluating and reducing genetic disease risks in future generations.